Berkshire Hathaway speeds up stock buybacks, though profit falls

Berkshire repurchased $9.6 billion of stock in Q3 and about $2 billion more in October, while ending September with $356.9 billion in cash and equivalents. Q3 operating earnings fell 6% to $12.71 billion and net earnings dropped 28% to $22.11 billion, despite revenue rising 11% to $105.65 billion; insurance results weakened, while BNSF profit increased 19% and energy profit rose 8%. Berkshire cited sluggish demand in some retail businesses and continued economic and geopolitical uncertainty, but its shares reached record highs and outgained the S&P 500 by more than 18 percentage points since September-end.

Analysis

Berkshire’s buyback pace is a capital-allocation signal, not proof the shares are cheap. As the stock rerates, each additional dollar may retire less value; the key missing check is average repurchase price versus a defensible estimate of intrinsic value. The remaining cash cushion limits near-term balance-sheet risk, but sustained repurchases would gradually reduce dry powder if attractive opportunities emerge.

Near term, recent relative strength looks vulnerable to reversal if quality/defensive flows fade. Over 1–3 months, the more important operating read-through is Geico: lowering premiums to win customers while the loss ratio rises risks trading underwriting quality for volume. Allstate and Progressive provide relevant benchmarks, but Berkshire’s limited disclosure makes the comparison imperfect. BNSF, energy and industrial strength offer some offset; consumer weakness and exposure to fuel-sensitive demand complicate the “defensive” label.

Over 6–18 months, Abel’s credibility depends less on deploying cash quickly than on demonstrating disciplined returns through the cycle. A renewed insurance margin decline, weaker consumer demand, or buybacks continuing at prices that do not clear intrinsic value would challenge the current quality premium. Conversely, improved Geico retention without further loss-ratio deterioration and disciplined capital allocation would validate it.

Key Decisions for Investors

• Do not chase BRK.A solely on buyback headlines or recent outperformance. Reassess after the next reporting cycle using repurchase prices, share count reduction, and cash balance; the thesis is weakened if buybacks continue while operating earnings deteriorate and the stock’s relative premium expands.
• Set a Geico alert: track loss ratio, policy/customer growth, and pricing at the next disclosure. If the loss ratio remains elevated while growth comes from discounting, consider a small long PGR / short BRK.A relative-value position, subject to valuation and broad insurance exposure checks. Exit the thesis if Geico’s loss ratio improves materially without renewed customer losses.
• For the next 1–3 months, treat BRK.A’s defensive bid as flow-sensitive rather than a confirmed earnings inflection. A reversal in relative performance versus the S&P 500 alongside weakening operating results would argue against adding; sustained outperformance plus improving insurance execution would falsify that caution.